Aescuvest
- Company typePrivate
- Founded2014
- HeadquartersFrankfurt, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
Aescuvest firmographics
Firmographics- Name
- Aescuvest
- Legal name
- Aescuvest GmbH
- Website
- https://aescuvest.eu
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Aescuvest industry classification
Industry- Product category
- Healthtech Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Other Financial Vehicles (52599)
- SIC
- Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)
- akta.pro primary industry
- Unit Registry & Transfer Agency for Alternatives (Private Funds, SPVs, Closed-End) (FSAAAMAK)
- akta.pro secondary industry
- Insurance General Accounts (Institutional Asset Owners) (FSAAAGAG)
Keywords
Where Aescuvest is headquartered
LocationHeadquarters
- HQ city
- Frankfurt
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Aescuvest business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Management Fees: Management fee charged on committed SPV capital. Fees are disclosed per deal in SPV documentation before any commitment.
- Carried Interest: Carried interest on profits from successful exits. Aescuvest co-invests in every round.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Aescuvest product offering
Product offeringCore offering
Aescuvest operates as a European deal-by-deal healthtech venture capital firm that sources, structures, and co-invests in individual healthtech rounds alongside business angels, family offices, and corporate partners. Each financing round is executed through a dedicated Special Purpose Vehicle (SPV), enabling qualified investors to review and commit to opportunities individually with full disclosure. The firm applies proprietary AI-assisted diligence (Acelia) and operates an investor portal plus a founder application platform (aescuvest.app) to manage deal flow, subscription, and reporting.
Product overview
Aescuvest operates as a deal-by-deal healthtech venture capital firm offering multiple interconnected products: its core SPV Investment Platform enables qualified investors to participate in individual healthtech funding rounds, while the Acelia AI diligence copilot accelerates due diligence evaluation. The aescuvest.app platform provides a gateway for healthtech founders to apply for funding with AI-assisted intake and scoring, and the Investor Portal on bunch.capital handles subscription management, legal documentation, and investor reporting across all SPVs.
Differentiator
Problem solved
Functional benefit
Products and services
- Aescuvest SPV Investment Platform A core venture capital platform that structures dedicated SPVs for each individual healthtech financing round, enabling qualified investors to participate in deals they select with full disclosure of terms, diligence packs, and term sheets before commitment.
- Acelia AI Diligence Copilot AI-powered diligence tool used during the due diligence process to accelerate evaluation of clinical, IP, regulatory, and financial information on potential portfolio companies.
- aescuvest.app Founder Application Platform AI-assisted deal-flow platform for healthtech founders to submit funding applications, featuring structured questionnaires, automated intake and scoring, and first-round diligence. Founders apply through the platform.
- Investor Portal (bunch.capital) Investor access portal hosted on bunch.capital for managing subscriptions, accessing legal documents, and viewing reporting for each SPV investment individually.
Quantifiable outcome
- Healthtech exit horizons run several years for early-stage rounds and shorter for later-stage approvals-track investments.
Companies that use Aescuvest
Customer profileSegments4 records
Ideal customer profiles5 records
Aescuvest technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Aescuvest partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- European and Middle Eastern NetworkscorePartnership networks across Europe and the Middle East that surface healthtech founders before broader networks see them. Provides first-look access to clinically validated, regulatory-aware teams.
Scale indicators2 records
Recent moves5 records
Expansion highlights5 records
Aescuvest competitors and assessment
Company assessmentDirect peers
- OurCrowd: OurCrowd is an Israel-based deal-by-deal venture investing platform with strong healthtech and deep-tech deal flow, allowing investors to subscribe to individual SPVs. Highly comparable to Aescuvest given shared geographic exposure (Israel/Middle East) and healthcare investment focus.
- Seedrs: Seedrs is a European private-investing platform that structures nominee/SPV wrappers for individual deals so investors can participate deal-by-deal. Comparable to Aescuvest in operating a regulated, deal-level SPV subscription model across Europe, though across sectors rather than healthtech-only.
- btov Partners: btov Partners is a European venture firm with a dedicated Digital Health and Industrial Tech franchise, investing across DACH and beyond. Comparable to Aescuvest as a European healthtech-focused VC serving a similar investor community.
- Heal Capital: Heal Capital is a European healthtech-focused venture fund backed by major insurers and corporates. Comparable to Aescuvest in its exclusive focus on digital health investing across Europe and emphasis on healthcare-industry LPs.
- Crowdcube: Crowdcube runs per-deal SPV-style structures for European private investments, enabling retail and qualified investors to subscribe to individual rounds. Comparable to Aescuvest in offering deal-by-deal transparency and SPV-based subscription mechanics in Europe.
- Earlybird Health: Earlybird's Health fund invests in European healthtech and digital health companies. Comparable to Aescuvest in targeting the same sub-vertical themes (digital diagnostics, personalised medicine) across DACH and broader Europe.
- AngelList (Ally): AngelList pioneered rolling-fund and SPV-by-deal structures for venture investing, allowing investors to back individual startups through dedicated vehicles. It is the closest direct competitor to Aescuvest's deal-by-deal SPV model, with a similar emphasis on investor transparency and per-deal subscription.
Regional players
- HV Capital: HV Capital is a German-headquartered European VC with a Health practice. Comparable as a DACH-rooted VC with healthtech exposure, though it operates a traditional fund structure rather than Aescuvest's SPV-by-deal approach.
Broad incumbents
- Speedinvest Health: Speedinvest operates a dedicated Health fund alongside broader consumer/tech funds, backing European digital health startups. Comparable as a European healthtech-active investor, but offers a much broader sector portfolio than Aescuvest's exclusive healthtech focus.
- Wellington Partners: Wellington Partners is a long-established European technology and healthcare VC firm with a dedicated life sciences practice. Comparable as a healthtech-active European VC but operating as a traditional blind-pool fund manager rather than deal-by-deal SPV platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Aescuvest social profiles
Digital presenceAescuvest financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aescuvest leadership team
Management profileNumber of profiles
Profiles5 records
Aescuvest funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aescuvest M&A and investment
M&A and investmentM&A
Investments25 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aescuvest
What does Aescuvest do?
Aescuvest operates as a European deal-by-deal healthtech venture capital firm that sources, structures, and co-invests in individual healthtech rounds alongside business angels, family offices, and corporate partners. Each financing round is executed through a dedicated Special Purpose Vehicle (SPV), enabling qualified investors to review and commit to opportunities individually with full disclosure. The firm applies proprietary AI-assisted diligence (Acelia) and operates an investor portal plus a founder application platform (aescuvest.app) to manage deal flow, subscription, and reporting.
Is Aescuvest a public or private company?
Aescuvest is a private company. It is classified as venture growth investor backed and is currently operating.
When was Aescuvest founded?
Aescuvest was founded in 2014. It employs 11 to 50 people.
Where is Aescuvest based?
Aescuvest is headquartered in Frankfurt, Germany, in the Europe region.
How does Aescuvest make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Who are Aescuvest's main competitors?
Direct peers on record are OurCrowd, Seedrs, btov Partners, Heal Capital, Crowdcube, Earlybird Health and AngelList (Ally). HV Capital is listed as a regional player. Broad incumbents are Speedinvest Health and Wellington Partners.
Does Aescuvest have an API?
No public API is recorded for Aescuvest.
What industry is Aescuvest in?
Aescuvest's product category is Healthtech Venture Capital. Its primary akta.pro industry code is FSAAAMAK, Unit Registry & Transfer Agency for Alternatives (Private Funds, SPVs, Closed-End), with a secondary code of FSAAAGAG, Insurance General Accounts (Institutional Asset Owners). Its NAICS code is 523940 and its SIC code is 6282.